Market Capitalization (Millions $) |
2,350 |
Shares
Outstanding (Millions) |
58 |
Employees |
- |
Revenues (TTM) (Millions $) |
69 |
Net Income (TTM) (Millions $) |
-203 |
Cash Flow (TTM) (Millions $) |
-120 |
Capital Exp. (TTM) (Millions $) |
6 |
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing therapies for rare genetic disorders of obesity. The company is committed to addressing the unmet medical needs of patients with these conditions and aims to improve their quality of life. Rhythm Pharmaceuticals utilizes a precision medicine approach to develop innovative therapies that target specific genetic mutations causing obesity-related disorders. Their research and development efforts are centered around a pipeline of potential treatments that aim to restore metabolic balance and help patients achieve sustainable weight loss and improvement in their overall health.
Company Address: 222 Berkeley Street Boston 2116 MA
Company Phone Number: 264-4280 Stock Exchange / Ticker: NASDAQ RYTM
|